Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Enveric Biosciences Inc (NQ: ENVB ) 0.5074 +0.0063 (+1.26%) Streaming Delayed Price Updated: 3:40 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Enveric Biosciences Inc < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More February 15, 2024 Via Benzinga Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More January 27, 2024 New study finds suggestibility plays a role in antidepressant effects of psilocybin therapy. EU invests 6.5M euros in psychedelics for pulmonary disorder, MS, ALS, and Parkinson's. Australian... Via Benzinga Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More January 12, 2024 Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD Via Benzinga 30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond January 10, 2024 The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic potential for substances like psilocybin and MDMA to treat mental health... Via Benzinga Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More January 07, 2024 Ibogaine Therapy Shows Promising Outcomes For Veterans With Trauma Brain Injury Via Benzinga Enveric Biosciences Updates Key Data Underpinning Selection of EB-003 as Lead Drug Candidate from EVM301 Series January 03, 2024 From Enveric Biosciences Via Business Wire 12 Health Care Stocks Moving In Monday's Pre-Market Session January 01, 2024 Via Benzinga Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session December 29, 2023 Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a December 2023 business update. Via Benzinga Enveric Biosciences Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $1.8 Million Gross Proceeds Priced At-the-Market December 29, 2023 From Enveric Biosciences Via Business Wire 12 Health Care Stocks Moving In Thursday's Pre-Market Session December 28, 2023 Via Benzinga Enveric Biosciences Selects EB-003 as Lead Drug Candidate from EVM301 Series December 28, 2023 From Enveric Biosciences Via Business Wire Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More December 27, 2023 President Biden Approves Psychedelics Clinical Trials For Active Military Members President Biden signed into law the 2024 National Defense Authorization Act (NDAA), large-scale legislation that also... Via Benzinga Enveric Biosciences Reports Year End Progress for Preclinical Development of Lead Prodrug Candidate EB-373 December 27, 2023 From Enveric Biosciences Via Business Wire 5 Biotech stocks tapping into unmet mental health treatment needs December 20, 2023 Here are five biotech companies currently working on drug candidates that tap into this soaring need for life-saving mental health treatments. Via MarketBeat Enveric Biosciences to Participate in Biotech Showcase 2024 During “J.P. Morgan Week 2024” December 20, 2023 From Enveric Biosciences Via Business Wire Psyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More December 18, 2023 Biden To Decide On Psychedelic Therapy Bill Via Benzinga Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More December 11, 2023 John Lennon Remembered 43 Years After His Murder In New York, Psychedelic Adventures & Enduring Legacy Via Benzinga Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More December 05, 2023 Defense Dept. Funds Ketamine Study For PTSD Treatment Via Benzinga Enveric Biosciences Selects Development Candidates from EVM301 Series Based on Potential to Minimize or Eliminate the Hallucinogenic Effect of Psychedelic-Derived Compounds December 05, 2023 From Enveric Biosciences Via Business Wire Enveric Biosciences Receives Notice of Allowance from USPTO for Development of Glycosylated Psilocybin Derivatives November 29, 2023 From Enveric Biosciences Via Business Wire Enveric Biosciences Announces Manuscript Describing the Development of Lead Product Candidate, EB-373, to be Featured on the Cover of the Journal of Medicinal Chemistry November 27, 2023 From Enveric Biosciences Via Business Wire Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More November 24, 2023 GOP Candidate Vivek Ramaswamy Wants Legal Psychedelics And Cannabis For PTSD In New Veterans Plan Via Benzinga Topics Cannabis Exposures Cannabis Enveric Biosciences Announces Presentation of Two Posters at Canadian Chemical Engineering Conference (CSChE 2023) November 24, 2023 From Enveric Biosciences Via Business Wire Enveric Biosciences' Revenue Drops In Q3 2023 As Next-Gen Psychedelics Advance To Clinical Trials November 14, 2023 Enveric Biosciences (NASDAQ: ENVB), a biopharma company developing novel neuroplastogenic small-molecule therapeutics for the treatment of anxiety, depression and addiction disorders, reported its... Via Benzinga Enveric Biosciences Reports Third Quarter 2023 Corporate and Financial Results November 13, 2023 From Enveric Biosciences, Inc. Via Business Wire Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More November 12, 2023 Veterans Day: Can Psychedelic Treatment Help Stem PTSD-Related Suicides Among Veterans? Via Benzinga Topics Initial Public Offering Exposures Securities Market Psyched: DEA's Denial Overruled, Fed Psychedelics Change, Psilocybin For Depression, States Reform & More November 06, 2023 DEA Psilocybin Rescheduling Denial Overruled By Federal Appeals Court Via Benzinga Topics Economy Exposures Interest Rates Psyched: Cybin's Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney's Memoirs And More October 29, 2023 Cybin Officially Owns Small Pharma, Gets Three New International Patents Granted Via Benzinga Topics Intellectual Property Exposures Intellectual Property Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted October 22, 2023 Jada Pinkett Smith Opens Up About Ayahuasca: It Helped Her Overcome Depression And Suicidal Thoughts Via Benzinga Enveric Biosciences to Present at the Centurion One 5th Global Summit October 20, 2023 From Enveric Biosciences Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.